173 related articles for article (PubMed ID: 19129850)
1. Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers.
Bos CL; van Baarsen LG; Timmer TC; Overbeek MJ; Basoski NM; Rustenburg F; Baggen JM; Thiesen HJ; Dijkmans BA; van der Pouw Kraan TC; Voskuyl AE; Verweij CL
Genes Immun; 2009 Apr; 10(3):210-8. PubMed ID: 19129850
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.
van der Pouw Kraan TC; Wijbrandts CA; van Baarsen LG; Voskuyl AE; Rustenburg F; Baggen JM; Ibrahim SM; Fero M; Dijkmans BA; Tak PP; Verweij CL
Ann Rheum Dis; 2007 Aug; 66(8):1008-14. PubMed ID: 17223656
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
[TBL] [Abstract][Full Text] [Related]
4. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
5. Type I interferon system activation and association with disease manifestations in systemic sclerosis.
Eloranta ML; Franck-Larsson K; Lövgren T; Kalamajski S; Rönnblom A; Rubin K; Alm GV; Rönnblom L
Ann Rheum Dis; 2010 Jul; 69(7):1396-402. PubMed ID: 20472592
[TBL] [Abstract][Full Text] [Related]
6. Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis.
Manetti M; Liakouli V; Fatini C; Cipriani P; Bonino C; Vettori S; Guiducci S; Montecucco C; Abbate R; Valentini G; Matucci-Cerinic M; Giacomelli R; Ibba-Manneschi L
Ann Rheum Dis; 2009 Mar; 68(3):408-11. PubMed ID: 18930992
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers.
Allanore Y; Borderie D; Meune C; Lemaréchal H; Weber S; Ekindjian OG; Kahan A
Ann Rheum Dis; 2005 Mar; 64(3):481-3. PubMed ID: 15708899
[TBL] [Abstract][Full Text] [Related]
8. Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles.
Zhou X; Tan FK; Xiong M; Arnett FC; Feghali-Bostwick CA
Arthritis Rheum; 2005 Oct; 52(10):3305-14. PubMed ID: 16200604
[TBL] [Abstract][Full Text] [Related]
9. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
[TBL] [Abstract][Full Text] [Related]
10. [Scleroderma--systemic sclerosis. Serology, lung function and survival].
Ullman S; Halberg P; Wiik A; Jacobsen S
Ugeskr Laeger; 1999 May; 161(21):3084-90. PubMed ID: 10377851
[TBL] [Abstract][Full Text] [Related]
11. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
Higgs BW; Liu Z; White B; Zhu W; White WI; Morehouse C; Brohawn P; Kiener PA; Richman L; Fiorentino D; Greenberg SA; Jallal B; Yao Y
Ann Rheum Dis; 2011 Nov; 70(11):2029-36. PubMed ID: 21803750
[TBL] [Abstract][Full Text] [Related]
12. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.
Marie I; Jouen F; Hellot MF; Levesque H
Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496
[TBL] [Abstract][Full Text] [Related]
13. Juvenile systemic sclerosis: report of three cases and review of Japanese published work.
Aoyama K; Nagai Y; Endo Y; Ishikawa O
J Dermatol; 2007 Sep; 34(9):658-61. PubMed ID: 17727371
[TBL] [Abstract][Full Text] [Related]
14. The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis.
Kampolis C; Plastiras S; Vlachoyiannopoulos P; Moyssakis I; Tzelepis G
Scand J Rheumatol; 2008; 37(4):278-83. PubMed ID: 18612928
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of 2'5'oligoadenylate synthetase and double-stranded RNA dependent protein kinase messenger RNAs on affected skin of systemic sclerosis patients.
Coelho LF; de Oliveira JG; de Oliveira DB; Guedes AC; Lanna CC; Prados RZ; Ferreira PC; Bonjardim CA; Kroon EG
Arch Dermatol Res; 2007 Aug; 299(5-6):259-62. PubMed ID: 17541615
[TBL] [Abstract][Full Text] [Related]
16. A subtype of multiple sclerosis defined by an activated immune defense program.
van Baarsen LG; van der Pouw Kraan TC; Kragt JJ; Baggen JM; Rustenburg F; Hooper T; Meilof JF; Fero MJ; Dijkstra CD; Polman CH; Verweij CL
Genes Immun; 2006 Sep; 7(6):522-31. PubMed ID: 16837931
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
18. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients.
Sebastiani M; Manfredi A; Colaci M; D'amico R; Malagoli V; Giuggioli D; Ferri C
Arthritis Rheum; 2009 May; 61(5):688-94. PubMed ID: 19405007
[TBL] [Abstract][Full Text] [Related]
19. Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody.
Komura K; Yanaba K; Ogawa F; Shimizu K; Takehara K; Sato S
Clin Exp Dermatol; 2008 May; 33(3):329-32. PubMed ID: 18312458
[TBL] [Abstract][Full Text] [Related]
20. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies.
Feghali-Bostwick C; Medsger TA; Wright TM
Arthritis Rheum; 2003 Jul; 48(7):1956-63. PubMed ID: 12847690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
